Lysosomal enzyme trafficking factor LYSET enables nutritional usage of extracellular proteins

Catarina Pechincha,Sven Groessl,Robert Kalis,Melanie de Almeida,Andrea Zanotti,Marten Wittmann,Martin Schneider,Rafael P de Campos,Sarah Rieser,Marlene Brandstetter,Alexander Schleiffer,Karin Müller-Decker,Dominic Helm,Sabrina Jabs,David Haselbach,Marius K Lemberg,Johannes Zuber,Wilhelm Palm,Rafael P. de Campos,Marius K. Lemberg
DOI: https://doi.org/10.1126/science.abn5637
IF: 56.9
2022-09-10
Science
Abstract:Mammalian cells can generate amino acids through macropinocytosis and lysosomal breakdown of extracellular proteins, which is exploited by cancer cells to grow in nutrient-poor tumors. Here, through genetic screens in defined nutrient conditions we characterized LYSET, a transmembrane protein (TMEM251) selectively required when cells consume extracellular proteins. LYSET was found to associate in the Golgi with GlcNAc-1-phosphotransferase, which targets catabolic enzymes to lysosomes through mannose-6-phosphate modification. Without LYSET, GlcNAc-1-phosphotransferase was unstable owing to a hydrophilic transmembrane domain. Consequently, LYSET-deficient cells were depleted of lysosomal enzymes and impaired in turnover of macropinocytic and autophagic cargoes. Thus, LYSET represents a core component of the lysosomal enzyme trafficking pathway, underlies the pathomechanism for hereditary lysosomal storage disorders, and may represent a target to suppress metabolic adaptations in cancer.
multidisciplinary sciences
What problem does this paper attempt to address?